Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice

MLA

Meng-Li, Wu, et al. “Combinational Benefit of Antihistamines and Remdesivir for Reducing SARS-CoV-2 Replication and Alleviating Inflammation-Induced Lung Injury in Mice.” Zoological Research, vol. 43, Jan. 2022, pp. 457–68. EBSCOhost, https://doi.org/10.24272/j.issn.2095-8137.2021.469.

APA

Meng-Li, W., Feng-Liang, L., Jing, S., Xin, L., Jian-Ru, Q., Qi-Hong, Y., Xia, J., Xin-Wen, C., Yong-Tang, Z., Jin-Cun, Z., & Jian-Hua, W. (2022). Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice. Zoological Research, 43, 457–468. https://doi.org/10.24272/j.issn.2095-8137.2021.469

Chicago

Meng-Li, Wu, Liu Feng-Liang, Sun Jing, Li Xin, Qin Jian-Ru, Yan Qi-Hong, Jin Xia, et al. 2022. “Combinational Benefit of Antihistamines and Remdesivir for Reducing SARS-CoV-2 Replication and Alleviating Inflammation-Induced Lung Injury in Mice.” Zoological Research 43 (January): 457–68. doi:10.24272/j.issn.2095-8137.2021.469.